WINREVAIR met primary endpoint of time to first morbidity or mortality event for the treatment of patients with pulmonary arterial hypertension (PAH) functional class III or IV at high risk of mortality
CPHI & PMEC India Expo 2024 to bring over 50,000 industry professionals and 2,000 exhibitors under one roof
Modernization and supply chain diversity drive new growth
Emraclidine was well-tolerated with an adverse event profile consistent with Phase 1b trial
Q2 FY25 Total Income was at Rs. 85.4 crore
JB’s domestic business continued to out-perform the market with all our major brands posting strong growth
The workshop aimed to equip medicos with the necessary skills & knowledge to leverage AI's transformative power
Spread over 1.26 lakh sq ft building, the super-specialty eye hospital will perform 30,000 free eye surgeries annually for economically weaker sections
Subscribe To Our Newsletter & Stay Updated
